Tirzepatide, especially at its higher doses, has been associated with slightly higher rates of nausea, vomiting, and diarrhea compared to semaglutide in some studies
For weight loss, tirzepatide slows gastric emptying, which slows down the passage of food in your stomach, says Dr
Practical considerations for patients When considering tirzepatide, whether under the brand name Mounjaro or Zepbound, patients should take into account several practical considerations to ensure safe and effective use: Administration and monitoring: Dosage : Begin with a usual initiation dose of 5 mg/0.5 mL injected subcutaneously once a week for Mounjaro and once every two weeks for Zepbound Monitoring : Schedule regular follow-ups to monitor hemoglobin A1c and body weight, adjusting the treatment plan as necessary Blood sugar levels : Maintain regular monitoring of blood sugar levels, especially crucial for those with type 2 diabetes Precautions and safety measures: Pregnancy : Use tirzepatide only if the potential benefit outweighs the risk to the fetus
This is one of the most common and most dangerous points of confusion in the entire GLP-1 space
Is there scientific evidence that semaglutide + B12 works better than semaglutide alone
This company has it together